ASX Delisting Information

Title	Type
EyePoint Extends Closing of Compulsory Sale Facility	EyePoint Extends Closing of Compulsory Sale Facility 30.5 KB
ASX Delisting - Notice of Revocation of Trust.	ASX Delisting - Notice of Revocation of Trust. 207 KB
Announcement of Approval to Delist From ASX and Letter to CDI Holders.	Announcement of Approval to Delist From ASX and Letter to CDI Holders. 2.7 MB
ASX Announcement - Suspension From Official Quotation	ASX Announcement - Suspension From Official Quotation 307.3 KB
pSivida Corp. Announces Plan to Delist From the Australian Securities Exchange	pSivida Corp. Announces Plan to Delist From the Australian Securities Exchange 78.8 KB
Delisting Letter and Timetable	Delisting Letter and Timetable 235.3 KB
Frequently Asked Questions	Frequently Asked Questions 202.4 KB
Form W-8 BEN	Form W-8 BEN 222 KB

EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2021 EyePoint Pharmaceuticals, Inc. All rights reserved.

09/2021
US-EYP-2100003